Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.

Rancea M, Skoetz N, Monsef I, Hübel K, Engert A, Bauer K.

J Natl Cancer Inst. 2012 Jul 18;104(14):NP. doi: 10.1093/jnci/djs278. Review. No abstract available.

PMID:
22825560
2.

Fourth biannual report of the Cochrane Haematological Malignancies Group.

Kober T, Hülsewede H, Bohlius J, Engert A.

J Natl Cancer Inst. 2006 Apr 19;98(8):E1. Review. No abstract available.

PMID:
16622111
3.

Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.

Bauer K, Herbst C, Brillant C, Monsef I, Kluge S, Skoetz N, Engert A.

J Natl Cancer Inst. 2010 Jun 16;102(12):E1. doi: 10.1093/jnci/djq188.

PMID:
20551424
4.

Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!

Borchmann P, Engert A, Diehl V.

Nat Rev Clin Oncol. 2011 Oct 4;8(11):636-7. doi: 10.1038/nrclinonc.2011.149. No abstract available.

PMID:
21971592
5.

Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.

Lim SH, Johnson PW.

Nat Rev Clin Oncol. 2011 Sep 6;8(11):634-6. doi: 10.1038/nrclinonc.2011.137. No abstract available.

PMID:
21894205
6.

[Hematologic tumors].

Ogawa M.

Gan To Kagaku Ryoho. 2003 Oct;30(10):1416-21. Review. Japanese.

PMID:
14584273
7.

Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.

Eckrich MJ, Domm J, Ho R, Whitlock JA, Frangoul H.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1327-8. doi: 10.1002/pbc.22182.

PMID:
19760777
8.

Chemotherapy for Hodgkin's disease.

Ekert H.

N Engl J Med. 2003 Sep 18;349(12):1186-7; author reply 1186-7. No abstract available.

9.
10.

Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.

Phipps C, Lee YS, Hwang W.

Br J Haematol. 2012 Oct;159(1):113-5. doi: 10.1111/j.1365-2141.2012.09234.x. Epub 2012 Jul 24. No abstract available.

PMID:
22823109
11.

[A case of Hodgkin's disease of mesenteric origin].

Morita M, Tani S, Hagihara R, Ryu Y, Yagi N, Yamashita J, Imanishi K, Kitazawa S.

Nihon Shokakibyo Gakkai Zasshi. 2002 Apr;99(4):391-6. Japanese. No abstract available.

PMID:
11979737
12.

Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.

Tesch H, Diehl V, Lathan B, Hasenclever D, Sieber M, Rüffer U, Engert A, Franklin J, Pfreundschuh M, Schalk KP, Schwieder G, Wulf G, Dölken G, Worst P, Koch P, Schmitz N, Bruntsch U, Tirier C, Müller U, Loeffler M.

Blood. 1998 Dec 15;92(12):4560-7.

13.

Is BEACOPP better than ABVD?

Cheson BD.

Curr Hematol Malig Rep. 2007 Jul;2(3):161-6. doi: 10.1007/s11899-007-0022-2. Review.

PMID:
20425365
15.

[Primary treatment of advanced Hodgkin's disease].

Illés A, Udvardy M, Molnár Z.

Orv Hetil. 2005 Jan 30;146(5):195-202. Review. Hungarian.

PMID:
15773586
16.

Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?

Eichenauer DA, Engert A.

Leuk Lymphoma. 2009 Nov;50(11):1733-4. doi: 10.3109/10428190903308098. No abstract available.

PMID:
19883301
17.

Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.

Rancea M, Will A, Borchmann P, Monsef I, Engert A, Skoetz N.

J Natl Cancer Inst. 2013 Aug 7;105(15):1159-70. doi: 10.1093/jnci/djt165. Epub 2013 Jul 12.

PMID:
23852951
18.

Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.

Carella AM, Pollicardo N, Pungolino E, Frassoni F, Giordano D, Bruni R, Spriano M, Rossi E.

Leuk Lymphoma. 1995;15 Suppl 1:59-61. No abstract available.

PMID:
7539318
19.

Will it be another 20 years before Hodgkin lymphoma patients benefit from BEACOPP therapy?

Diehl V, Engert A.

Nat Clin Pract Oncol. 2006 May;3(5):227. No abstract available.

PMID:
16682982
20.

Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.

Mian M, Farsad M, Pescosta N, Casini M, Cavattoni IM, Deola S, Cortelazzo S.

Ann Hematol. 2013 Jan;92(1):121-3. doi: 10.1007/s00277-012-1525-z. Epub 2012 Jul 22. No abstract available.

PMID:
22820997

Supplemental Content

Support Center